IMU Biosciences
IMU Biosciences is a developer of a high-resolution immune system decoding and multi-omic analysis platform. From its funding announcement.
In their own words
What IMU Biosciences says it is doing
Public signal Described in the funding announcement as "developer of a high-resolution immune system decoding and multi-omic analysis platform". Source
Public signal Read from the company's own description of what the funding supports.
Why now
Where IMU Biosciences is today
IMU Biosciences announced a Series A round of $53M on 2 June 2026, led by IQ Capital and Molten Ventures.
Momentum AfterRaise intelligence
AfterRaise Score
- Hiring momentum Open roles and hiring pace
- Market expansion New offices and new countries
- Leadership Executive appointments
- Product activity Launches and releases
Since the raise
What has happened since
- 2 June 2026$53M Series ALed by IQ Capital and Molten Ventures.
Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.
What may happen next
What this raise could create
What may happen next
- New market entry
- First local hires in the new market
- Local entity and legal setup
- Product launches and new tiers
Opportunities this could create
- Revenue operations
- Security and SOC 2
- Cloud infrastructure
- Channel partnerships
- Market-entry advisers
Based on the Enterprise Software sector, a Series A round and the priorities the company itself set out. Not a statement of fact.
- 2 June 2026$53M Series A announced
- 2 June 2026Stated priority: market expansion
- 2 June 2026Stated priority: product
- 2 June 2026Stated priority: research and development
- 2 June 2026Stated priority: infrastructure
High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.
Open to
What IMU Biosciences is open to
Not yet specified
IMU Biosciences has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.
Work here? Set your preferencesOpportunities
Ways to work with IMU Biosciences
No open opportunities listed
Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.
Work here? Open the first oneHelpful contributors
People who have contributed here
Nobody yet
When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.
Do you work at IMU Biosciences?
Claim your company profile.
This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.
What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.
Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.
Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.
Also moving